Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15908529 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Nab-Paclitaxel

Study has passed its completion date and status has not been verified in more than two years.